Results 1 to 10 of about 1,890,375 (406)

Enhanced vaccine control of epidemics in adaptive networks [PDF]

open access: yes, 2009
We study vaccine control for disease spread on an adaptive network modeling disease avoidance behavior. Control is implemented by adding Poisson distributed vaccination of susceptibles. We show that vaccine control is much more effective in adaptive networks than in static networks due to an interaction between the adaptive network rewiring and the ...
Ira B. Schwartz   +4 more
arxiv   +5 more sources

Measuring routine childhood vaccination coverage in 204 countries and territories, 1980–2019: a systematic analysis for the Global Burden of Disease Study 2020, Release 1 [PDF]

open access: yes, 2021
Background: Measuring routine childhood vaccination is crucial to inform global vaccine policies and programme implementation, and to track progress towards targets set by the Global Vaccine Action Plan (GVAP) and Immunization Agenda 2030.
Vaccine Coverage Collaborators,
core   +1 more source

BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting

open access: yesNew England Journal of Medicine, 2021
Background As mass vaccination campaigns against coronavirus disease 2019 (Covid-19) commence worldwide, vaccine effectiveness needs to be assessed for a range of outcomes across diverse populations in a noncontrolled setting.
N. Dagan   +9 more
semanticscholar   +1 more source

Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant

open access: yesNew England Journal of Medicine, 2022
Background A rapid increase in coronavirus disease 2019 (Covid-19) cases due to the omicron (B.1.1.529) variant of severe acute respiratory syndrome coronavirus 2 in highly vaccinated populations has aroused concerns about the effectiveness of current ...
N. Andrews   +30 more
semanticscholar   +1 more source

Effectiveness of influenza vaccination in patients with end-stage renal disease receiving hemodialysis: a population-based study. [PDF]

open access: yes, 2013
BackgroundLittle is known on the effectiveness of influenza vaccine in ESRD patients. This study compared the incidence of hospitalization, morbidity, and mortality in end-stage renal disease (ESRD) patients undergoing hemodialysis (HD) between cohorts ...
Chang, Chiz-Tzung   +9 more
core   +17 more sources

Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19

open access: yesNew England Journal of Medicine, 2021
Background The Ad26.COV2.S vaccine is a recombinant, replication-incompetent human adenovirus type 26 vector encoding full-length severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein in a prefusion-stabilized conformation.
J. Sadoff   +29 more
semanticscholar   +1 more source

COVID-19 Vaccine Hesitancy Worldwide: A Concise Systematic Review of Vaccine Acceptance Rates

open access: yesVaccines, 2021
Utility of vaccine campaigns to control coronavirus 2019 disease (COVID-19) is not merely dependent on vaccine efficacy and safety. Vaccine acceptance among the general public and healthcare workers appears to have a decisive role in the successful ...
Malik Sallam
semanticscholar   +1 more source

Subclass and avidity of circumsporozoite protein specific antibodies associate with protection status against malaria infection

open access: yesnpj Vaccines, 2021
RTS,S/AS01 is an advanced pre-erythrocytic malaria vaccine candidate with demonstrated vaccine efficacy up to 86.7% in controlled human malaria infection (CHMI) studies; however, reproducible immune correlates of protection (CoP) are elusive. To identify
Kelly E. Seaton   +16 more
doaj   +1 more source

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

open access: yesNew England Journal of Medicine, 2020
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and the resulting coronavirus disease 2019 (Covid-19) have afflicted tens of millions of people in a worldwide pandemic.
F. Polack   +28 more
semanticscholar   +1 more source

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

open access: yesNew England Journal of Medicine, 2020
Background Vaccines are needed to prevent coronavirus disease 2019 (Covid-19) and to protect persons who are at high risk for complications. The mRNA-1273 vaccine is a lipid nanoparticle–encapsulated mRNA-based vaccine that encodes the prefusion ...
L. Baden   +36 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy